Velia is a biotech company that discovers and develops the therapeutic potential of human proteins.
Velia has raised $55.0M in total funding. The most recent round was Series A. The last funding was announced in January 2022.
Velia's investors include Foresite Capital, The Column Group.
Velia is headquartered in San Diego, United States.
Velia is a biotech company that discovers and develops the therapeutic potential of human proteins.
Velia is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Velia — Funding & Investors." VCBacked, January 1, 2022, https://www.vcbacked.co/company/velia. Accessed September 13, 2026.
VCBacked. (2022). Velia — Funding & Investors. Retrieved September 13, 2026, from https://www.vcbacked.co/company/velia
{{cite web |title=Velia — Funding & Investors |url=https://www.vcbacked.co/company/velia |website=VCBacked |access-date=September 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated